Regeneron says Covid antibody treatment protects for 8 months
By AFP
November 09, 2021
Washington: A synthetic antibody treatment developed by Regeneron reduced the risk of developing symptomatic Covid by more than 80 percent up to eight months after receiving the treatment, the US biotech firm said Monday.
The results are "particularly important to those who do not respond to Covid-19 vaccines including people who are immunocompromised," said Myron Cohen, a University of North Carolina at Chapel Hill scientist who is leading a government-sponsored study into the treatment.
-
Harry Styles Opens Up About Isolation After One Direction Split -
Shamed Andrew Was ‘face To Face’ With Epstein Files, Mocked For Lying -
Kanye West Projected To Explode Music Charts With 'Bully' After He Apologized Over Antisemitism -
Leighton Meester Reflects On How Valentine’s Day Feels Like Now -
Sarah Ferguson ‘won’t Let Go Without A Fight’ After Royal Exile -
Adam Sandler Makes Brutal Confession: 'I Do Not Love Comedy First' -
'Harry Potter' Star Rupert Grint Shares Where He Stands Politically -
Drama Outside Nancy Guthrie's Home Unfolds Described As 'circus' -
Marco Rubio Sends Message Of Unity To Europe -
Savannah's Interview With Epstein Victim, Who Sued UK's Andrew, Surfaces Amid Guthrie Abduction -
Piers Morgan Supports Bad Bunny As US Lawmakers Seek Action -
Jennifer Love Hewitt Reminisces About Workign With Betty White -
Hilarie Burton Reveals Valentine's Day Plans With Jeffrey Dean Morgan -
Harry Styles Silently Deleted Instagram App -
Cardi B Compares Her Fall To Government At Las Vegas Show -
Harry Styles Reveals Biggest Lesson Learnt During Music Hiatus